✦ LIBER ✦

HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of eNOS

✍ Scribed by Dong-Ju Choi; Eun-Ji Kim; Min-Jung Park; Jung-Won Suh; Hyuk-Jae Chang; Young-Seok Cho; Tae-Jin Yeon; In-Ho Chae; Kwang-Il Kim; Cheol-Ho Kim; Hyo-soo Kim; Buyng-Hee Oh; Young-Bae Park

Book ID: 118418906
Publisher: Atlantis Press
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 3
Category: Article
ISSN: 1872-9312
DOI: 10.1016/j.artres.2009.06.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The HMG-CoA reductase inhibitor, pravast

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

✍ Pascal Guerard; Zo Rakotoniaina; Françoise Goirand; Luc Rochette; Monique Dumas; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 640 KB

HMG CoA reductase inhibitor suppresses t

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

✍ Yasufumi Kunieda; Katsumi Nakagawa; Hiromi Nishimura; Hisato Kato; Naoki Ukimura 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Lipophilic HMG-CoA reductase inhibitor h

Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells

✍ Ikuo Inoue; Sei-ichi Goto; Kasumi Mizotani; Takuya Awata; Toshiyuki Mastunaga; S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 826 KB